DavidAMankoffMD

Professor, Radiology, University of Washington School of Medicine

Dr. Mankoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Spruce St
Philadelphia, PA 19104
Phone+1 215-614-1926

Fax+1 215-349-5843

Komen Scholar Susan G. Komen Foundation
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Whos Who in Medicine and Healthcare Marquis Whos Who

PubMed

Upstaging of Invasive Lobular Cancer With FES PET/CT.
Saud Rehman, Christine E Edmonds, David A Mankoff, Austin R Pantel, Sophia R O'Brien
Clinical Nuclear Medicine. 2025-03-01
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export.
Hoon Choi, Mamta Gupta, Arjun Sengupta, Emma E Furth, Christopher Hensley
Neoplasia. 2025-03-01
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer.
Natasha B Hunter, Lanell M Peterson, Jennifer M Specht, David A Mankoff, Mark Muzi
Breast Cancer Research. 2025-02-17

Journal Articles

Test-Retest Reproducibility of FDG-PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
Jennifer M Specht, Jean H Lee, Hannah M Linden, Andrew T Shields, David A Mankoff, Paul E Kinahan, Journal of Nuclear Medicine
Glutamate-Weighted Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (GluCEST MRI) Detects Glutaminase Inhibition in a Mouse Model of Triple-Negative Br...
Ravinder Reddy, David Mankoff, Clinical Cancer Research

Lectures

Molecular Imaging and Targeted Therapy
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)May 24th, 2023
How One Doctor-Patient Relationship Could Change How Women Are Treated for Gynecologic CancersFebruary 2nd, 2023
Awards & Accolades: May 2021June 9th, 2021
Join now to see all

PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast CancerUNIVERSITY OF PENNSYLVANIA2022–2027
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & CommercializationUNIVERSITY OF PENNSYLVANIA2021–2026
Research Track Radiology ResidencyUNIVERSITY OF PENNSYLVANIA2005–2025
Advanced PET/CT Imaging For Improving Clincail TrialsNational Cancer Institute2010–2012
PET To Measure Breast Cancer Bone Metastasis ResponseNational Cancer Institute2007–2011
Estrogen Receptor Positive Breast Cancer And Its Response To TherapyNational Cancer Institute2007–2008
Estrogen Receptor Positive Breast Cancer And TherapyNational Cancer Institute2004–2006
Imaging The Response Of Locally Advanced Breast CancerNational Cancer Institute1996–2006
Diagnosis Of IM Nodal Metastases In Breast CancerNational Cancer Institute2001–2004
Imaging For Evaluation Of Clinical Vaccine EfficacyNational Cancer Institute2001–2002
PET Imaging Of Estrogen Receptors In Breast CancerNational Cancer Institute1998–2002
Positron Tomograph Using Optically Coupled DetectorsNational Cancer Institute1990
Single-Crystal, Cylindrical Position TomographNational Institute Of Neurological Disorders And Stroke1988